Author:
Kaspers G. J. L.,Zwaan Ch. M.,Pieters R.,Veerman A. J. P.
Reference32 articles.
1. Creutzig U, Rittter J, Schellong G. Identification of two risk groups in childhood acute myelogeneous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 1990, 75:1932–1940
2. Pui Ch. Childhood leukemias. New Engl J Med 1995, 332:1618–1630
3. Stevens RF, Hann IM, Wheatley K, Gray RG, on behalf of the MRC Childhood Leakemia Working Party. Marked improvements in outcome with chemotherapy alone in paediatric acute myedloid leukaemia: results of the United Kingdom Medical research Council’s 10th AML trial. Br J Haematol 1998, 101:130–140
4. Pieters R, Kaspers GJL, Veerman AJP. Drug sensitivity culture assays in childhood leukemia: A review of the results and applications. Int J Pediatr Hematol Oncol 1997, 4:531–541
5. Preisler HD, Gopal V. Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment. Leuk Res 1994, 18:149–160
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献